REM1
COURTESY REMINDER - SEC. 8 (6-YR) E-MAILED
07/28/2025
Back to search
Official data from USPTO
XCOPRI
Did you know this trademark is already registered in United States?
Before investing in name, identity, and promotion, validate collision risk and registration strategy to avoid wasting time and budget.
Active USPTO registrationType: CombinedOffice: United States
Risk and opportunity diagnosis
Executive reading for naming, filing, and monitoring decisions.
USPTO status
Active USPTO registration
Case type
Application and registration
Recorded events
22
Latest update
07/29/2025
Trademark type
Combined
Nice classes
5
Filing date
06/24/2019
Registration date
07/28/2020
Expiration date
-
Complete case details
Structured fields from the responsible authority and the official record.
Status date
07/28/2020
Last transaction
07/29/2025
Responsible office
United States Patent and Trademark Office
Status code
700
Official register
Principal Register
Filing basis
Intent to use, Foreign priority
Drawing code
3
Owner type
03
Owner location
Seongnam-si, KR
Examiner
AGREDA, SAMANTHA
Law office
N50
Current location
PUBLICATION AND ISSUE SECTION
Mark description
The mark consists of the stylized word "XCOPRI" in purple upper case letters. The backwards slash in the letter "X" is formed by a red triangular design. The remaining color white represents background and is not a feature of the mark.
Holders and representatives
Holders
SK BIOPHARMACEUTICALS CO., LTD.
Representatives
Hun Joon Kim LEX IP Meister, PLLC.
Technical classification
Nice Classes
Class 5
Vienna Codes
No Vienna codes available.
Goods and services
Class 5
Medicines for human purposes and veterinary preparations for treatment of central nervous system diseasescancer and metabolic diseases; sanitary preparations for medical use; biological preparations for medical purposesfor the treatment of central nervous system diseasescancer and metabolic diseases; biochemical preparations for medical purposesfor the treatment of central nervous system diseasescancer and metabolic diseases; chemical preparations for pharmaceutical purposesfor the treatment of central nervous system diseasescancer and metabolic diseases; medical preparation of trace elements for human and animal usefor the treatment of central nervous system diseasescancer and metabolic diseases; ferments for pharmaceutical purposes; biotechnological preparations for medical purposesfor the treatment of central nervous system diseasescancer and metabolic diseases; chemical preparations for medicinal purposesfor the treatment of central nervous system diseasescancer and metabolic diseases; chemical preparations for medical or veterinary purposesfor the treatment of central nervous system diseasescancer and metabolic diseases; chemical preparations for sanitary use; pharmaceutical preparations for immunity adjustment; vitamin preparations; vaccines; dietary supplements; therapeutic drugs and agents for the treatment of central nervous system diseasescancer and metabolic diseases; chemico-pharmaceutical preparations for the treatment of central nervous system diseasescancer and metabolic diseases; bacteriological preparations for medical and veterinary use; blood solventblood plasmaalbuminglobulinfibrinogenthrombocyte and platelets
Publications
History of USPTO decisions and trademark events.
22 publications found
TCCA
TEAS CHANGE OF CORRESPONDENCE RECEIVED
11/27/2024
ECDR
TEAS CHANGE OF DOMESTIC REPRESENTATIVES ADDRESS
11/27/2024
ARAA
ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
11/27/2024
REAP
TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
11/27/2024
R.PR
REGISTERED-PRINCIPAL REGISTER
07/28/2020
NPUB
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
05/12/2020
PUBO
PUBLISHED FOR OPPOSITION
05/12/2020
NONP
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
04/22/2020
CNSA
APPROVED FOR PUB - PRINCIPAL REGISTER
04/07/2020
TEME
TEAS/EMAIL CORRESPONDENCE ENTERED
03/24/2020
CRFA
CORRESPONDENCE RECEIVED IN LAW OFFICE
03/24/2020
ALIE
ASSIGNED TO LIE
03/23/2020
ERSI
TEAS RESPONSE TO SUSPENSION INQUIRY RECEIVED
03/16/2020
DOCK
ASSIGNED TO EXAMINER
10/07/2019
GNS3
NOTIFICATION OF LETTER OF SUSPENSION E-MAILED
09/16/2019
GNSL
LETTER OF SUSPENSION E-MAILED
09/16/2019
CNSL
SUSPENSION LETTER WRITTEN
09/16/2019
DOCK
ASSIGNED TO EXAMINER
09/12/2019
MDSC
NOTICE OF DESIGN SEARCH CODE E-MAILED
07/03/2019
NWOS
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
07/02/2019
NWAP
NEW APPLICATION ENTERED
06/27/2019
Continuous trademark protection
Get notified about every new filing that threatens XCOPRI or your mark.
Professional 24-month watch service: we monitor USPTO for you and alert you in time to oppose — before conflicts become losses.